Primary ovarian malignant mixed Müllerian tumor: a rare case report.
Ther Adv Rare Dis
; 3: 26330040221107389, 2022.
Article
em En
| MEDLINE
| ID: mdl-37180422
Primary ovarian malignant mixed Müllerian tumor: a rare case report Ovarian carcinomas: These are the most common type of ovarian cancer. About two-thirds of these cancers are of epithelial origin. Obesity, hormone replacement therapy, not having children, and family history of ovarian cancer are risk factors for ovarian cancer. A neoplasm is a type of abnormal and excessive growth of tissue. Neoplasms arising from more than one cell type or germ layer are called 'mixed tumors'. Ovarian carcinosarcoma, also known as a malignant mixed Müllerian tumor (MMMT) of the ovary, is a rare, aggressive cancer of the ovary with characteristics of two types of cancer: carcinoma and sarcoma. In this case, we reported a very uncommon and rapidly progressive tumor with a high chance of death even with an advance treatment protocol. Because women with this cancer often have no symptoms, more than half of women are diagnosed at an advanced stage. These cancer cells spread first from surface of the ovary to the lining and organs of the pelvis and abdomen and then to other parts of the body. Diagnosis of ovarian cancer starts with a physical examination, a blood test (for CA-125 and sometimes other markers), transvaginal ultrasound, CT scanning, and so on. The diagnosis must be confirmed with surgery to inspect the abdominal cavity and take biopsies for microscopic analysis. Required advanced ovarian cancer treatment depend on various factors, such as surgery, chemotherapy, radiation, hormonal therapy, and palliative care as per required. Message: Primary ovarian MMMT is an extremely uncommon neoplasm, and in this case we showed a patient with an extensive aggressive clinical course, and even with surgery, chemotherapy, and adjuvant therapy, it showed poor prognosis.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Ther Adv Rare Dis
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Índia